Serko Limited — Director's Dealing 2023

Jun 16, 2023

==> picture [98 x 24] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		Serko Limited
Date this disclosure made:		16-Jun-23
Date of last disclosure:		2-Jul-20
Director or senior managergivingdisclosure
Full name(s):		Robert Clyde McConaghy
Name of listed issuer:		Serko Limited
Name of related bodycorporate(if applicable):		Not applicable
Position held in listed issuer:		Director
Summary of acquisition or disposal of relevant interest(excluding specified derivatives)
Class of affectedquoted financialproducts:		Ordinaryshares
Nature of the affected relevant interest(s):		Registered holder and beneficial owner of shares by virtue of Mr McConaghy being a trustee (and beneficiary of) the Portofino Trust).
For that relevant interest-
Number held in class before acquisition or disposal:		181,818
Number held in class after acquisition or disposal:		146,818
Current registered holder(s):		Robert Clyde McConaghy as Trustee of Portofino Trust
Registered holder(s)once transfers are registered:		Unknown
Details of transactionsgiving rise to acquisition or disposal
Total number of transactions to which notice relates:		2
Details of transactions requiring disclosure-
Date of transaction:		1) 13 June 2023 2) 14 June 2023.
Nature of transaction:		Two separate market (ASX) sell transactions
Name of anyotherpartyorparties to the transaction(if known):		Unknown
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration:		1) 21,621 ordinary shares: $69,546.28 AUD x FX rate 1.10 (2dp) = $76,500.91 NZD (2dp) 2) 13,379 ordinary shares: $43,481.75 x FX rate 1.10 ( 2 dp) = $47,829.93 NZD (2dp) Total NZD consideration:$124,330.84
Number of financialproducts to which the transaction related:		35,000
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details—
Whether relevant interests were acquired or disposed of duringa closedperiod:		No
Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period:		Not applicable
Date of theprior written clearance(if any):		Not applicable
Summary of other relevant interests after acquisition or disposal:
Class ofquoted financialproducts:		Ordinaryshares
Nature of relevant interest:		Registered holder and beneficial owner
_For that relevant interest,- _
Number held in class:		1,091
Current registered holder(s):		Robert Clyde McConaghy
For a derivative relevant interest,-
Type of derivative:		Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):		Not applicable
A statement as to whether the derivative is cash settled orphysicallysettled:		Not applicable
Maturitydate of the derivative(if any):		Not applicable
Expirydate of the derivative(if any):		Not applicable

The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: Certification I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature:

Not applicable Not applicable Not applicable Not applicable 16-Jun-23